<DOC>
	<DOCNO>NCT02214862</DOCNO>
	<brief_summary>The PET tracer [ F18 ] -FDDNP specific affinity lesion contain tau protein . The study consist two phase : - In first ( cross-sectional ) phase assess uptake [ 18F ] -FDDNP 10 case progressive supranuclear palsy ( PSP , tauopathy ) en 10 multi-system atrophy ( MSA , non-tauopathy ) , along 20 individual Unclassifiable Parkinsonism , previously define European cohort study . - In second ( longitudinal ) phase prospectively follow 20 unclassifiable patient ( 6 , 12 18 month ) mean validated scale accept diagnostic criterion order try correlate eventual clinical diagnosis baseline PET finding . On basis , endeavour estimate ability technique detect vivo underlie tau pathology subject initially unclassifiable clinical ground . We hypothesize : 1 . Patients clinically definite PSP present increase uptake basal ganglion , brainstem cerebellum . 2 . Patients clinically define MSA present specific uptake . 3 . Part unclassifiable patient parkinsonism present pattern uptake similar patient clinically define PSP part along clinical follow-up meet clinical criterion diagnose PSP</brief_summary>
	<brief_title>2- ( 1- { 6- ( 2-F-18Fluoroethyl ) ( Methyl ) Amino-2-naphthyl } Ethylidene ) Malononitrile-PET Vivo Diagnose Tauopathy Unclassified Parkinsonism</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Parkinsonian Disorders</mesh_term>
	<mesh_term>Supranuclear Palsy , Progressive</mesh_term>
	<mesh_term>Tauopathies</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Radiopharmaceuticals</mesh_term>
	<criteria>The subject male female â‰¥ 40 year old ; The individual one three condition : probable PSP accord criterion National Institute Neurological Disorders Stroke ( NINDS ) probable MSA accord criterion Second consensus statement diagnosis multiple system atrophy unclassifiable parkinsonism accord criterion define Katzenschlager et al , 2003 : Patients atypical parkinsonism without response treatment levodopa meet diagnostic criterion know atypical parkinsonism Patient give write consent The subject diagnose Parkinson 's Disease meet diagnostic criterion United Kingdom Parkinson 's Disease Society Brain Bank The subject pregnant breastfeeding ; The subject history drug abuse alcohol ; The subject moderate severe renal function impairment ( creatinine serum &gt; 1.5 mg / dL ) ; The subject moderate severe hepatic impairment ( bilirubin &gt; 2 time upper limit normal , transaminases &gt; 3 time limit top normal ) ; The subject present structural abnormality basal ganglia cortical level MRI CT ; The subject participate clinical study pharmaceutical product investigation within 30 day prior screen / radiopharmaceutical minimum period 5 radioactive halflives prior screen ; Occupational exposure radiation &gt; 15 milliSievert ( mSv ) / year Use nonsteroidal antiinflammatory drug ( NSAIDs ) , reason , replace drug 4 week PET scan ; The subject allergy investigational product component ; The subject clinically severe active disease , hope reduce life ; The subject claustrophobic / .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Unclassifiable Parkinsonism , [ F18 ] -FDDNP-PET , Tauopathy , PSP , MSA</keyword>
</DOC>